Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of asthma phenotype on disease control
2013-004905-15Phase 3Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of terbutaline, budesonide and formoterol in asthma (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Improvement of airway hyperresponsiveness to mannitol. Started Jan 2014; status: completed.
02
Drugs
terbutalinebudesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-004905-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004905-15.